Consider the question that usually ends a doctor’s appointment: Which pharmacy? It sounds like a matter of geography. Near home, perhaps, or on the way to work. Yet choosing a pharmacy also means choosing a price, often before the patient has seen one. Prescryptive Health has built its business around that peculiar order of operations. What happens if the price arrives before the destination is settled?
- Patients get prescription alerts and can compare pharmacy options on a phone.
- Employers buy pharmacy benefits with a flat administrative fee and pass-through pricing.
- Community pharmacies use AI Pricing to tune cash prices to their own markets.
The receipt arrives early
The patient-facing product, myPrescryptive, starts with a text. A prescriber can send a digital prescription to the patient’s mobile phone; the patient then compares prices and locations and chooses where to fill it. The company reported more than 60,000 participating pharmacies in April 2023. That is a network of dispensing businesses, not a chain of Prescryptive-owned shops.
A discount search usually begins with a drug name. Here, the prescription itself becomes the starting point. The distinction matters: the company wants the conversation about affordability to happen while the prescriber and patient can still discuss options. Its platform compares cash and insurance pricing and surfaces potentially less expensive medications within a member’s benefits plan.
The less theatrical features may be the useful ones. There is no app to download. A digital medicine cabinet holds prescription history, a spending summary helps members track benefit expenses, and caregivers can manage prescriptions for dependents. Someone keeping track of a family’s medicines can appreciate a single place to look without needing a lecture about digital transformation.
gets a head start.Official myPrescryptive product screen
A cloud company walks into a pharmacy
Chris Blackley and Kevin Young founded Prescryptive in 2017 after working at Microsoft. Blackley, now CEO, had spent 14 years there in licensing and pricing. His earlier experience included founding a pharmacy technology company. Young is Prescryptive’s chief product officer. Their background helps explain the combination: complex commercial arrangements underneath, a relatively simple interface on top.
In August 2020, Prescryptive raised a $26 million Series A led by Morningside Ventures, with SeaChange Fund and Pallasite Ventures participating. GeekWire reported total funding of $35 million at that point. In September 2022, it acquired Northwest Pharmacy Services, a regional pharmacy benefit manager. That purchase brought existing benefit relationships and staff into the technology business.
The technical foundation includes blockchain-based prescription management, with a first patent announced in 2021. But the practical test is whether a prescription can travel through existing systems. Prescryptive says its platform is Surescripts certified and compatible with pharmacy systems meeting NCPDP electronic-prescribing standards. Its expertise has to include pharmacists, benefits administration and integration as well as software.
Who pays when the price comes down?
For employers, the offering is emPBM, a pharmacy benefit management service aimed at plan sponsors and their members. Prescryptive describes a flat per-member, per-month administrative fee, with pharmacy prices and manufacturer rebates passed through to the sponsor. Its stated PBM revenue model removes the spread between what it pays a pharmacy and what it bills an employer.
That makes the contract part of the product. The employer is buying benefit administration, clinical programs, reporting and member engagement. The patient gets the mobile experience through that arrangement. Pharmacy pricing tools and manufacturer partnerships extend the business beyond employers. Prescryptive sits between several markets: benefits administration, prescription shopping and the infrastructure connecting drug companies to patients.
Alternatives depend on the buyer. GoodRx is an alternative for consumer prescription-price shopping; SmithRx and Navitus operate in employer pharmacy benefits. Prescryptive’s particular proposition combines the patient’s prescription, pharmacy choice and benefit information in one workflow. A cheaper quote alone would be a narrower product. The pitch here depends on making the quote actionable.
Four stores changed the conversation
Boone Drugs provides a useful glimpse of what needed adjustment. In 2023, the pharmacy business started a cash-pricing program at four stores. Standard pricing did not offer enough customization, according to vice president Spencer Hodges. The team switched to Prescryptive AI Pricing, which lets pharmacies tailor pricing to their requirements. An initial approach had reached its limit; the response was a more adjustable one.
“We started on standard pricing with Prescryptive, but we needed more.”Spencer Hodges, PharmD · Boone Drugs
In Prescryptive’s published case study, Boone reported gross margin per prescription rising 25% after two weeks, 32% after four weeks and 37% after three months. It expanded the tool to 12 stores. These are vendor-published observations from September 2023 through January 2024. They describe pharmacy economics, and should not be mistaken for patient savings or a controlled comparison.
Chancy Drugs, a seven-location Georgia business, reported up to roughly $4 more profit per cash prescription against historic claims, with average patient cash payments just under $24. The apparent tension is instructive. Helping a pharmacy price more intelligently can mean raising some prices that were too low. Pharmacy profitability and patient affordability must be measured separately, even when the company promises both.
The next prescription is infrastructure
The recent partnerships expand that ambition. In January 2026, Prescryptive and Ilant Health announced employer-direct access to obesity care and GLP-1 therapies, combining pricing and benefit execution with Ilant’s clinical oversight. In May, Prescryptive announced that its technology helps power LillyDirect, connecting pricing, fulfillment, patient consent and coordination. The company is selling the connections behind the experience.
Trust matters when those connections carry medical information. Prescryptive announced HITRUST e1 certification for its core platform in September 2025. Its published values put customers, technology and impact at the center of its work. Those are stated intentions; the observable business choices are more revealing: a phone-based experience, pharmacy tools and contracts designed around explicit administration fees.
The lesson readers can borrow is specific: show the price while someone can still act on it, then test the change in a small setting. Boone’s four-store rollout is a practical example. The conditions matter, too. Patients need usable digital access, participating pharmacies and clinically appropriate options. Employers need contracts that match their benefits. A visible price cannot manufacture an available drug or make an unsuitable alternative appropriate.
Explore the prescription
Take a closer look at the products, people and conversations.